Navigation Links
SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
Date:2/25/2008

DUBLIN, Calif., Feb. 25 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that it will release its 2007 fourth quarter and fiscal year-end financial results on Monday, Mar. 3, 2008. SuperGen Management will provide details of the Company's financial results, and provide financial guidance for fiscal year-end 2008.

A press release will be transmitted to the news media immediately following the close of the market on Mar. 3, 2008. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast is accessible via the investor relations section of the Company's Web site at http://www.supergen.com. A webcast replay of the live conference call will be available for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

Contacts:

SuperGen SuperGen

Timothy L. Enns Mary M. Vegh

S.V.P., Corporate Communications Manager, Investor Relations

& Business Development (925) 560-2845

(925) 560-0100 x111 mary.vegh@supergen.com

tenns@supergen.com


'/>"/>
SOURCE SuperGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
2. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
3. Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress
4. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
5. Aton Pharma Announces the Appointment of Dr. Fred Eshelman to Management Board
6. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
7. Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc.
8. Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business
9. Masimo Announces Continuous Noninvasive Total Hemoglobin
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):